Improved survival and high sustained virologic response with DAA therapy in patients with HCV‐related HCC: A call for expanded use-Reference-Cited by-同舟云学术

Improved survival and high sustained virologic response with DAA therapy in patients with HCV‐related HCC: A call for expanded use

Published:2021-02-08 Issue:6 Volume:36 Page:1721-1722
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Ji F¹²^ORCID,Li T¹,Nguyen MH³⁴^ORCID

Affiliation:

1. Department of Infectious Diseases the Second Affiliated Hospital of Xi'an Jiaotong University Xi'an China

2. National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy the Second Affiliated Hospital of Xi'an Jiaotong University Xi'an China

3. Division of Gastroenterology and Hepatology Stanford University Medical Center Palo Alto California USA

4. Department of Epidemiology and Population Health Stanford University Palo Alto California USA

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15420

Reference12 articles.

1. Treatment of hepatitis C virus infection in patients with hepatocellular carcinoma: truth or dare?;Mocan T;J. Gastroenterol. Hepatol.,2020

2. Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis

3. Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication

4. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

5. Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment rates and factors associated with direct‐acting antiviral therapy for insured patients with hepatitis C‐related hepatocellular carcinoma – A real‐world nationwide study;Alimentary Pharmacology & Therapeutics;2023-11-08

2. Antiviral Therapy for Hepatitis C Virus Infection in Cirrhosis;Pharmacotherapy for Liver Cirrhosis and Its Complications;2022